Careers Print Text Size

Myelodysplastic Syndromes Treatment Options

De Novo and Secondary Myelodysplastic Syndromes

Treatment of de novo and secondary myelodysplastic syndromes may include the following:

  • Supportive care with transfusion therapy
  • High-dose chemotherapy with stem cell transplant using stem cells from a donor
  • Supportive care with growth factor therapy
  • Chemotherapy with azacitidine, decitabine, or other anticancer drugs
  • Supportive care with drug therapy
  • A clinical trial of a new anticancer drug
  • A clinical trial of low-dose chemotherapy with stem cell transplant using stem cells from a donor
  • A clinical trial of a combination of treatments
  • A clinical trial of growth factor therapy

Previously Treated Myelodysplastic Syndromes

Treatment of previously treated myelodysplastic syndromes may include the following:

  • High-dose chemotherapy with stem cell transplant using stem cells from a donor
  • Chemotherapy with azacitidine or decitabine
  • Supportive care with transfusion therapy, growth factor therapy, and/or drug therapy
  • A clinical trial of low-dose chemotherapy with stem cell transplant using stem cells from a donor
  • A clinical trial of new drug therapy
  • A clinical trial of a combination of treatments
  • A clinical trial of growth factor therapy